Product Information
NITROFURANTOIN MCR 50 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1650 per EA under NDC 59651075301. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Jul 9, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651075301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOINApproval Type
Generic (ANDA)
FDA Application
ANDA074967FDA Approved
7/9/1997
TE Code
AB
On Market Since
5/12/2023
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MCR 50 MG CAP has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 46.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1650 per EA |
|---|---|
| All-time high | $0.3101 (Mar 13, 2024) |
| All-time low | $0.1396 (May 20, 2026) |
| 52-week high | $0.1866 |
| 52-week low | $0.1396 |
| Median price | $0.1869 |
| Average price | $0.1879 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the nitrofurantoin (macrocrystals) market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nitrofurantoin (macrocrystals) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MCR 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MCR 50 MG CAP, manufactured by Aurobindo Pharma Limited, is $0.1650 per EA (NDC 59651075301), effective Sep 30, 2026.
How has the price of NITROFURANTOIN MCR 50 MG CAP changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MCR 50 MG CAP has declined 46.5%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MCR 50 MG CAP?
Since Feb 14, 2024, the NADAC for NITROFURANTOIN MCR 50 MG CAP has ranged from a low of $0.1396 (May 20, 2026) to a high of $0.3101 (Mar 13, 2024), with a median of $0.1869 per EA.
Are there cheaper alternatives to NITROFURANTOIN MCR 50 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of NITROFURANTOIN MCR 50 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NITROFURANTOIN MCR 50 MG CAP?
NITROFURANTOIN MCR 50 MG CAP (NDC 59651075301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.